Skip to main content
SpringerLink
Log in
Book cover

Bacterial Infections of Humans pp 349–366Cite as

Leprosy

  • Chapter

  • 130 Accesses

Abstract

Leprosy (Hansen’s disease) is a chronic infectious disease caused by Mycobacterium lepraethat primarily affects the skin, peripheral nerves, eyes, and mucous membranes. It has been known for well over 2000 years and afflicts more than 11 million people worldwide, mostly in underdeveloped nations. Hansen(31) discovered the etiological agent over 100 years ago, but it has still not definitely been cultured in artificial media, and there is much about the disease process we do not understand. In particular, relatively few good studies on the epidemiology and control of leprosy have been done.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abe, M., Fluorescent leprosy antibody absorption (Fla-Abs) test for detecting subclinical infection with Mycobacterium leprae, Int. J. Lepr. 47:379 (1979) (abstract).

    Google Scholar 

  2. Amezcua, M. E. , Escobar-Gutiérrez, A., Mayen, E., and Cazares, J. V., Sensitivity and specificity of the FLA-ABS test for leprosy in Mexican populations, Int. J. Lepr. 55:277– 285 (1987).

    Google Scholar 

  3. Badger, L. F. , Leprosy in the United States, Public Health Rep. 70:525–535 (1955).

    PubMed  CAS  Google Scholar 

  4. Badger, L. F. , Epidemiology, in: Leprosy in Theory and Practice, 2nd ed. (R. G. Cochrane, and T. F. Davey, eds.), pp. 69–97, John Wright, Bristol, 1964.

    Google Scholar 

  5. Bahong, J., and Noordeen, S. K. , Leprosy, in: Tropical Disease Research: A Global Partnership (J.Maurice and A. M. Pearce, eds.), pp. 113–124, WHO, Geneva, 1987.

    Google Scholar 

  6. Bechelli, L. M. , Garbojosa, P. G., Gyi, M. M. , and Martinez-Dominguez, V. , Site of early skin lesions in children with leprosy, Bull. WHO 48:107–111 (1973).

    PubMed  CAS  Google Scholar 

  7. Bechelli, L. M., Lwin, K., Garbajosa, P. G., Gyi, M. M., Uemura, K. , Sundaresan, T. , Tamondong, C., Matejka, M., Sansarricq, H., and Walter, J., BCG vaccination of children against leprosy: Nine-year findings of the controlled WHO trial in Burma, Bull. WHO 51:93–99 (1974).

    PubMed  CAS  Google Scholar 

  8. Brown, J. A. K., Stone, M. M., and Southerland, J., Trial of BCG vaccination against leprosy in Uganda, Lepr. Rev. 40:3–7 (1969).

    PubMed  CAS  Google Scholar 

  9. Browne, S. G., The history of leprosy, in: Leprosy(R. C. Hastings, ed.), pp. 1–14, Churchill Livingstone, Edinburgh, 1985.

    Google Scholar 

  10. Brubaker, M. L., Binford, C. H., and Trautman, J. R., Occurrence of leprosy in U.S. veterans after service in endemic areas abroad, Public Health Rep. 84:1051–1058 (1969).

    PubMed  CAS  Google Scholar 

  11. Bullock, W. E., Studies of immune mechanisms in leprosy. I. Depression of delayed allergic responses to skin test antigens, N. Engl. J. Med. 278:298–304 (1968).

    Google Scholar 

  12. Chacko, C. J. G., Mohan, M., Jesudasan, K., Job, C. K., and Fritschi, E. P. , Primary leprosy involvement of nasal mucosa in apparently healthy household contacts of leprosy patients, Int. J. Lepr. 47:417 (1979) (abstract).

    Google Scholar 

  13. Chakravatti, M. R., and Vogel, F., A twin study on leprosy, Topics in Human Genetics, No. 1, Thieme, Stuttgart, 1973.

    Google Scholar 

  14. Clark-Curtiss, J. E. , Jacobs, W. R. , Docherty, M. A., Ritchie, L. A. , and Curtiss, R. , Molecular analysis of Dna and construction of genomic libraries of Mycobacterium leprae, J. Bacteriol. 161:1093–1102 (1985).

    PubMed  CAS  Google Scholar 

  15. Closs, O., In vitrolymphocyte response to purified protein derivative, Bcg and Mycobacterium leprae ina population not exposed to leprosy, Infect. Immun. 11:1163–1169 (1975).

    PubMed  CAS  Google Scholar 

  16. Convit, J., Aranzazu, N., Ulrich, M., Pinardi, M. E., Reyes, O., and Alvarado, J. , Immunotherapy with a mixture of Mycobacterium lepraeand Bcg in different forms of leprosy and in Mitsuda-negative contacts, Int. J. Lepr. 50:415–424 (1982).

    CAS  Google Scholar 

  17. Davey, T. F., and Rees, R. J. W., The nasal discharge in leprosy: Clinical and bacteriologic aspects, Lepr. Rev. 45:121–134 (1974).

    PubMed  CAS  Google Scholar 

  18. Desikan, K. B., Viability of Mycobacterium lepraeoutside the human body, Lepr. Rev. 48:231–235 (1977).

    PubMed  CAS  Google Scholar 

  19. Dharmendra and Chatterjee, B. R. , Prognostic value of the lepromin test in contacts of leprosy cases, Lepr. India 27:149–158 (1955).

    Google Scholar 

  20. Donham, K. J. , and Leininger, J. R. , Spontaneous leprosy-like disease in a chimpanzee, J. Infect. Dis. 136:132–136 (1977).

    PubMed  CAS  Google Scholar 

  21. Drutz, D. J., Chen, T. S. N., and Lu, W. H., The continuous bacteremia of lepromatous leprosy, N. Engl. J. Med. 287:159–164 (1972).

    PubMed  CAS  Google Scholar 

  22. Enna, C. D. , Jacobson, R. R. , Trautman, J. R. , and Sturdivant, M. , Leprosy in the United States, 1967–1976, Public Health Rep. 93:468–473 (1978).

    PubMed  CAS  Google Scholar 

  23. Faget, G. P. , Pogge, R. C., Johansen, F. A. , Dinan, J. F. , Prejean, B. M. , and Eccles, C. G. , The promin treatment of leprosy: A progress report, Public Health Rep. 58:1729–1741 (1943).

    CAS  Google Scholar 

  24. Filice, G. A. , and Fraser, D. W. , Management of household contacts of leprosy patients, Ann. Intern. Med. 88:538–542 (1978).

    PubMed  CAS  Google Scholar 

  25. Fisher, C. A. , and Barksdale, L. , Elimination of the acidfastness but not the gram positivity of leprosy bacilli after extraction with pyridine, J. Bacteriol. 106:707–708 (1971).

    PubMed  CAS  Google Scholar 

  26. Godal, T. , and Negassi, K. , Subclinical infection in leprosy, Br. Med. J. 3:557–559 (1973).

    PubMed  CAS  Google Scholar 

  27. Godal, T. , Lofgren, M. , and Negassi, K. , Immune response to Mycobacterium lepraeof healthy leprosy contacts, Int. J. Lepr. 40:243–250 (1972).

    CAS  Google Scholar 

  28. Gormus, B. J., Wolf, R. H., Baskin, G. B., Ohkawa, S. G., Walsh, P. J., Meyers, W. M., Binford, C. H., and Greer, W. E. , A second sooty mangabey monkey with naturally acquired leprosy: First reported possible monkey-tomonkey transmission, Int. J. Lepr. 56:61–65 (1988).

    CAS  Google Scholar 

  29. Gray, H. H. , and Dreisbach, J. A. , Leprosy among foreign missionaries in northern Nigeria, Int. J. Lepr. 29:279–290 (1961).

    PubMed  CAS  Google Scholar 

  30. Guinto, R. S. , Epidemiology of leprosy: Current views, concepts and problems, in: A Window on Leprosy(B. R. Chatterjee, ed.), pp. 36–53, Statesman Commercial Press, Calcutta, 1978.

    Google Scholar 

  31. Hansen, G. H. A., Undersogelser angaende Spedalskhedens Arsager, Nor. Mag. Laegevidensk. 4:76–79 (1874).

    Google Scholar 

  32. Harboe, M., The immunology of leprosy, in: Leprosy(R. C. Hastings, ed.), pp. 53–87, Churchill Livingstone, Edinburgh, 1985.

    Google Scholar 

  33. Harboe, M., and Closs, O., A revival of interest in antibody studies in leprosy? Int. J. Lepr. 47:372 (1979) (abstract).

    Google Scholar 

  34. Hastings, R. C., Transfer factor as a probe of the immune deficit in lepromatous leprosy, Int. J. Lepr. 45:281–291 (1977).

    CAS  Google Scholar 

  35. Immunological problems in leprosy research (2), Bull. WHO 48:483–492 (1973).

    Google Scholar 

  36. Ingrens, L. M. , and Kazda, J., The epidemiological significance of the occurrence of M. leprae-likemicroorganisms in the environment, Int. J. Lepr. 52:719 (1984).

    Google Scholar 

  37. Job, C. K. , Chacko, C. J. G. , Taylor, P. M. , Daniel, M., and Jesudian, G., Evaluation of cell mediated immunity in the histopathologic spectrum of leprosy using lymphocyte transformation test, Int. J. Lepr. 44:256–266 (1976).

    CAS  Google Scholar 

  38. Job, C. K., Harris, E. B. , Allen, J. L. ,and Hastings, R. C. , A random survey of leprosy in wild nine-banded armadillos in Louisiana, Int. J. Lepr. 54:453–457 (1986).

    CAS  Google Scholar 

  39. Khandekar, P. S. , Munshi, A. , Sinha, S. , Sharma, G., Kapoor, A., Gaur, A. , and Talwar, G. P. , Construction of genomic libraries of mycobacterial origin: Identification of recombinants encoding mycobacterial-specific proteins, Int. J. Lepr. 54:416–422 (1986).

    CAS  Google Scholar 

  40. Kirchheimer, W. F., and Prabhakaran, K., Metabolic and biologic tests on mycobacteria once labeled as leprosy bacilli, Int. J. Lepr. 36:589 (1968).

    Google Scholar 

  41. Kirchheimer, W. F. , and Storrs, E. E. , Attempts to establish the armadillo (Dasypus novencintusLinn.) as a model for the study of leprosy. I. Report of lepromatoid leprosy in an experimentally infected armadillo, Int. J. Lepr. 39:693–702 (1971).

    CAS  Google Scholar 

  42. Kluth, F. C., Leprosy in Texas: Risk of contracting the disease in the household, Tex. State J. Med. 52:758–789 (1956).

    Google Scholar 

  43. Krieg, R. E., and Meyers, W. M., Demonstration of Mycobacterium lepraein tissues from bacteriologically negative treated lepromatous leprosy patients, Int. J. Lepr. 47:367 (1979) (abstract).

    Google Scholar 

  44. Lechat, M. F., Bellut, C., and Mission, C. B., The use and limitations of epidemiometric models in leprosy, in: A Window on Leprosy(B. R. Chatterjee, ed.), pp. 64–70, Statesman Commercial Press, Calcutta, 1978.

    Google Scholar 

  45. Leiker, D. L., Epidemiological and immunological surveys in Netherlands New Guinea, Lepr. Rev. 31:241–259 (1960).

    Google Scholar 

  46. Leprosy-like disease in wild-caught armadillos, Morbid. Mortal. Weekly Rep. 25:18, 23 (1976).

    Google Scholar 

  47. Lim, S. E. , Kiszkiss, E. F. , Jacobson, R. R. , Choi, Y. S., and Good, R. A., Thymus-dependent lymphocytes of peripheral blood in leprosy patients, Infect. Immun. 9:394–399 (1974).

    PubMed  CAS  Google Scholar 

  48. Lumpkin, L. R. , III, Cox, G. F. , and Wolf, J. E., Jr., Leprosy in five armadillo handlers, J. Am. Acad. Dermatol. 9:899–903 (1983).

    PubMed  Google Scholar 

  49. Mathai, R. , Rao, P. S. S. , and Job, C. K. , Risks of treating leprosy in a general hospital, Int. J. Lepr. 47:322 (1979) (abstract).

    Google Scholar 

  50. Mehra, V., Mason, L. H., Fields, J. P., and Bloom, B. R. , Lepromin induced suppressor cells in patients with leprosy, J. Immunol. 123:1813–1817 (1979).

    PubMed  CAS  Google Scholar 

  51. Menzel, S., Bjune, G., Kronvall, G., and Morrow, R. H. , Lymphocyte transformation test in healthy leprosy contacts: Influence of household exposure, Int. J. Lepr. 47:374 (1979) (abstract).

    Google Scholar 

  52. Meyers, W. M. , Kvernes, S. , and Binford, C. H. , Comparison of reactions to human and armadillo lepromins in leprosy, Int. J. Lepr. 43:218–225 (1975).

    CAS  Google Scholar 

  53. Mohamed Ali, P. , and Ramanujam, K., Leprosy in twins, Int. J. Lepr. 34:405–407 (1966).

    Google Scholar 

  54. Narayanan, E. , Sreevatsa Kirchheimer, W. F., and Bedi, B. M. S., Transfer of leprosy bacilli from patients to mouse footpads by Aedes aegypti, Lepr. India 49:181–186 (1977).

    PubMed  CAS  Google Scholar 

  55. Nathan, C. F., Kaplan, G., Levis, W. R., Nusrat, A., Witmer, M. D., Sherwin, S. A., Job, C. K., Horowitz, C. R. , Steinman, R. M. , and Cohn, Z. A. , Local and systemic effects of intradernal recombinant interferon-γ in patients with lepromatous leprosy, N. Engl. J. Med. 315:6–15 (1986).

    PubMed  CAS  Google Scholar 

  56. Nelson, E. E. , Wong, L. , Uyemura, K. , Rea, T. H. , and Modlin, R. L. , Lepromin-induced suppressor cells in lepromatous leprosy, Cell. Immunol. 104:99–104 (1987).

    PubMed  CAS  Google Scholar 

  57. Newell, K. W. , An epidemiologist’s view of leprosy, Bull, WHO 34:827–857 (1966).

    CAS  Google Scholar 

  58. Noordeen, S. K., Longterm effects of chemoprophylaxis among contacts of lepromatous cases, Lepr. India 49:504–509 (1977).

    PubMed  CAS  Google Scholar 

  59. Noordeen, S. K., and Lopez-Bravo, L., The world leprosy situation, World Health Stat. Q. 39:122–128 (1986).

    PubMed  CAS  Google Scholar 

  60. Noussitou, F. M. , Sansarricq, H. , and Walter, J. , Leprosy in Children, WHO, Geneva, 1976.

    Google Scholar 

  61. Oleinick, A. , Altered immunity and cancer risks: A review of the problem and analysis of the cancer mortality experience of leprosy patients, J. Natl. Cancer Inst. 43:775–781 (1969).

    PubMed  CAS  Google Scholar 

  62. Pattyn, S. R. , Comportement de diverses espéces de mycobactéries dans la patte de souris, Ann. Inst. Pasteur 109:309–313 (1965).

    CAS  Google Scholar 

  63. Pattyn, S. R. , Use of the mouse footpad in studying thermoresistance of Mycobacterium leprae, Int. J. Lepr. 33:611–615 (1965).

    PubMed  Google Scholar 

  64. Pedley, J. C. , The hypothesis of skin to skin transmission, Lepr. Rev. 48:295–297 (1977).

    PubMed  CAS  Google Scholar 

  65. Prabhakaran, K. , Harris, E. B. , and Kirchheimer, W. F. , Survival of Mycobacterium lepraein tissues kept frozen at 80°C, Microbios Lett. 1:193–195 (1976).

    Google Scholar 

  66. Prabhakaran, K. , and Kirchheimer, W. F. , Use of 3,4-dihydroxyphenylalanine oxidation in the identification of Mycobacterium leprae, J. Bacteriol, 92:1267–1268 (1966).

    PubMed  CAS  Google Scholar 

  67. Rasi, E. , Castellazzi, Z. , Garcia, L. , Quevedo, L. , and Convit, J. , Evaluation of “chemical isolation” in 1,168 leprosy patients’ homes, Int. J. Lepr. 43:101–105 (1975).

    CAS  Google Scholar 

  68. Rea, T. H. , Current concepts in the immunology of leprosy, Arch. Dermatol. 113:345–352 (1977).

    PubMed  CAS  Google Scholar 

  69. Rees, R. J. W., The microbiology of leprosy, in: Leprosy(R. C. Hastings, ed.), pp. 31–52, Churchill Livingstone, Edinburgh, 1985.

    Google Scholar 

  70. Rees, R. J. W., and Mcdougall, A. C., Airborne infection with Mycobacterium leprae in mice, J. Med. Microbiol. 10:63–68 (1977).

    PubMed  CAS  Google Scholar 

  71. Rees, R. J. W., and Meade, T. W., Comparison of modes of spread and incidence of tuberculosis and leprosy, Lancet 1:47–49 (1974).

    PubMed  CAS  Google Scholar 

  72. Report of the Workshop on Microbiology of the Xi International Leprosy Congress, Int. J. Lepr. 47:291–294 (1979).

    Google Scholar 

  73. Ridley, D. S. , and Jopling, W. H. , A classification of leprosy for research purposes, Lepr. Rev. 33:119–128 (1962).

    PubMed  CAS  Google Scholar 

  74. Rotberg, A., Bechelli, L. M. , and Keil, H. , The Mitsuda reaction in a non-leprous area, Int. J. Lepr. 18:209–220 (1950).

    Google Scholar 

  75. Russell, D. A., Worth, R. M., Scott, G. C., Vincin, D. R. , Jano, B. , Fasal, P. , and Shepard, C. C. , Experience with acedapsone (Dadds) in a therapeutic trial in New Guinea and the chemoprophylactic trial in Micronesia, Int. J. Lepr. 44:170–176 (1976).

    CAS  Google Scholar 

  76. Sansarricq, H. , Walter, J. , and Seal, K. S. , The World Health Organization in leprosy control, in: A Window on Leprosy(B. R. Chatterjee, ed.), pp. 12–22, Statesman Commercial Press, Calcutta, 1978.

    Google Scholar 

  77. Schauf, V. , Ryan, S. , Scollard, D. , Jonasson, O., Brown, A., Nelson, K. , Smith, T. , and Vithayasai, V., Leprosy associated with Hla-DR2 and DQw1 in the population of northern Thailand, Tissue Antigens, 26:243–247 (1985).

    PubMed  CAS  Google Scholar 

  78. Seckl, M. J., Monoclonal antibodies and recombinant Dna technology: Present and future uses in leprosy and tuberculosis, Int. J. Lepr. 53:618–640 (1985).

    CAS  Google Scholar 

  79. Sehgal, V. M., Rege, V. L., and Singh, K. P., The age of onset of leprosy, Int. J. Lepr. 45:52–55 (1977).

    CAS  Google Scholar 

  80. Shepard, C. C., The experimental disease that follows the injection of human leprosy bacilli into footpads of mice, J. Exp. Med. 112:445–454 (1960).

    PubMed  CAS  Google Scholar 

  81. Shepard, C. C., Stability of Mycobacterium lepraeand temperature optimum for growth, Int. J. Lepr. 33:541–547 (1965).

    PubMed  Google Scholar 

  82. Shepard, C. C., Experimental chemotherapy in leprosy, then and now, Int. J. Lepr. 41:307–319 (1973).

    CAS  Google Scholar 

  83. Shepard, C. C., and Mcrae, D. H., Mycobacterium leprae in mice:Minimal infectious dose, relationship between staining quality and infectivity, and effect of cortisone, J. Bacteriol. 89:365–372 (1965).

    PubMed  CAS  Google Scholar 

  84. Shepard, C. C., and Saitz, E. W., Lepromin and tuberculin reactivity in adults not exposed to leprosy, J. Immunol. 99:637–642 (1967).

    PubMed  CAS  Google Scholar 

  85. Shepard, C. C., Walker, L. L., and Vanlandingham, R. , Heat stability of Mycobacterium lepraeimmunogenicity, Infect. Immun. 22:87–93 (1978).

    PubMed  CAS  Google Scholar 

  86. Shield, M. J., Stanford, J. L., and Rook, G. A. W., The reason for the reduction of the protective efficacy of Bcg in Burma, Int. J. Lepr. 47:319–320 (1979) (abstract).

    Google Scholar 

  87. Skinsnes, O. K. , Matsuo, E. , Chang, P. H. C., and Andersson, B., Cultivation of Mycobacterium lepraein hyaluronic acid based medium. 1. Preliminary report, Int. J. Lepr. 43:193–203 (1975).

    CAS  Google Scholar 

  88. Van Eden, W., Gonzalez, N. M., De Vries, R. R., Convit, J., and Van Rood, J. J., Hla-linked control of predisposition to lepromatous leprosy, J. Infect. Dis. 151:9–14 (1985).

    PubMed  Google Scholar 

  89. Wade, H. W. , and Ledowsky, V. , The leprosy epidemic at Nauru: A review with data on status since 1937, Int. J. Lepr. 20:1–29 (1952).

    PubMed  CAS  Google Scholar 

  90. Waldorf, D. S., Sheagren, J. N., Trautman, J. R., and Block, J. B., Impaired delayed hypersensitivity in patients with lepromatous leprosy, Lancet 2:773–776 (1966).

    PubMed  CAS  Google Scholar 

  91. Walsh, G. P. , Storrs, E. E. , Burchfield, H. P. , Cottrell, E. H., Vidrine, M. F., and Binford, C. H., Leprosy-like disease occurring naturally in armadillos, J. Reticuloendothel. Soc. 18:347–351 (1975).

    PubMed  CAS  Google Scholar 

  92. Wardekar, R. V. , Chemoprophylaxis in leprosy, Lepr. India 41:240–246 (1969).

    Google Scholar 

  93. Waters, M. F. R., Significance of the lepromin test in tuberculin-negative volunteers permanently resident in a leprosyfree area, Int. J. Lepr. 41:563 (1973).

    Google Scholar 

  94. Waters, M. F. R., Rees, R. J. W., Pearson, J. M. H., Laing, A. B. G., Helmy, H. S., and Gelber, R. H., Rifampicin for lepromatous leprosy: Nine years’ experience, Br. Med. J. 1:133–136 (1978).

    PubMed  CAS  Google Scholar 

  95. Waters, M. F. R., Rees, R. J. W., Laing, A. B. G., Fah, K. K., Meade, T. W. , Parikshak, N., and North, W. R. S., The rate of relapse in lepromatous leprosy following completion of 20 years of supervised sulfone therapy, Lepr. Rev. 57:101–109 (1986).

    PubMed  CAS  Google Scholar 

  96. WHO Expert Committee on Leprosy, Fifth Report, WHO Tech. Rep. Ser.No. 607, WHO, Geneva, 1977.

    Google Scholar 

  97. WHO Study Group, Chemotherapy of Leprosy for Control Programmes, WHO Tech. Rep. Ser.No. 675, WHO, Geneva, 1982.

    Google Scholar 

  98. Worth, R. M., and Wong, K. O., Further notes on the incidence of leprosy in Hong Kong children living with a lepromatous parent, Int. J. Lepr. 38:745–749 (1971).

    Google Scholar 

  99. Young, D. B., and Buchanan, T. M., A serological test for leprosy with a glycolipid specific for Mycobacterium leprae, Science 221:1057–1059 (1983).

    PubMed  CAS  Google Scholar 

  100. Young, R. A., Mehra, V. , Sweetser, D., Buchanan, T., Clark-Curtiss, J., Davis, R. W., and Bloom, B. R., Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae, Nature 316:450–452 (1985).

    PubMed  CAS  Google Scholar 

Suggested Reading

  • Bahong, J. , and Noordeen, S. K. , Leprosy, in: Tropical Disease Research: A Global Partnership(J. Maurice and A. M. Pearce, eds.), pp. 113–124, WHO, Geneva, 1987.

    Google Scholar 

  • Harboe, M. (ed.), Immunology of Leprosy: Proceedings of an International Symposium, Lepr. Rev. 57(Suppl. 2): 1–308 (1986).

    Google Scholar 

  • Hastings, R. C. (ed.), Leprosy, Churchill Livingstone, Edinburgh, 1985.

    Google Scholar 

  • WHO Study Group, Chemotherapy of Leprosy for Control Programmes, WHO Tech. Rep. Ser.No. 675, WHO, Geneva, 1982.

    Google Scholar 

  • World Health Organization, A Guide to Leprosy Control, Publ. No. ISBN 92–4–154147–4, Geneva, 1980.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinical Branch, Gillis W. Long Hansen’s Disease Center, Carville, Louisiana, 70721, USA

    Robert R. Jacobson

Authors
  1. Robert R. Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Yale University School of Medicine, New Haven, Connecticut, USA

    Alfred S. Evans (John Rodman Paul Professor of Epidemiology, Emeritus) (John Rodman Paul Professor of Epidemiology, Emeritus)

  2. Emory University School of Public Health, Atlanta, Georgia, USA

    Philip S. Brachman

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jacobson, R.R. (1991). Leprosy. In: Evans, A.S., Brachman, P.S. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1211-7_16

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-1211-7_16

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-1213-1

  • Online ISBN: 978-1-4757-1211-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation